Exelon Is Down 9%. Why Its Recovery Is Beating History
Exelon Is Down 9% in 130 Days. Why Its Recovery Is Beating History
Exelon Corporation (EXC) is down 9% from its all-time high as of July 31, 2026, having just exited the yellow zone after spending 130 days in drawdown. The Drawdown Severity Score™ has improved to 1.9, signaling a transition to the green zone much faster than the historical 285-day average recovery duration for drops of 5% or more. In the 44 comparable prior drops of this depth, the stock typically faced prolonged consolidations, making the current rapid recovery notable for this regulated utility.
Drawdown Severity Score™
Down 9% over 130 days. This is within the normal range for this asset.
Article data as of July 31, 2026
1.90
Price
$45.82
All-Time High
$50.29
Drawdown
-8.9%
Duration
130 days
Exelon Exits the Yellow Zone After 130 Days
Exelon spent the last several months navigating the yellow zone, a phase of elevated drawdown risk that began as the stock pulled back from its all-time high of $50.29. The current price of $45.82 represents a -8.9% drawdown. This 130-day period of consolidation tested investor patience but did not spiral into a deep sell-off.
The transition from the yellow zone to the green zone indicates that the selling pressure has exhausted itself. This shift occurred as buyers stepped in to support the stock well before it reached historical capitulation levels. Our data shows that the severity score has now moderated to 1.9, which is classified as Slightly Elevated.
EXC Drawdown History
Percentage below all-time high over time
Article data
-8.9%
July 31, 2026
The Pure-Play Utility Advantage Post-Spin-Off
The shift in Exelon's market dynamics is closely tied to its operating model. Since spinning off its power generation business, Constellation Energy, in 2022, Exelon has operated as a pure-play transmission and distribution utility. This rate-regulated business model provides highly predictable cash flows, making the stock less vulnerable to economic cyclicality.
Historically, utility stocks carrying merchant energy exposure faced highly volatile earnings due to commodity price swings. By removing that volatility, Exelon transformed into a pure regulated play with a lower risk profile. This structural change explains why the stock is finding support earlier in its drawdown cycle than it has historically.
Earnings Stability and Dividend Payments Support the Price Floor
Recent financial results reinforce this defensive profile. According to TradingView, Exelon's second-quarter earnings came in line with estimates as revenues rose year-over-year. Yahoo Finance Singapore reported that key metrics matched expectations, reassuring investors who rely on the company for stable dividend income.
Additionally, stocktitan.net noted that Exelon set a September 15 date for its $0.42 per share shareholder payment, confirming the steady cash return profile that supports the stock's floor. This recession-proof cash flow profile, as highlighted by TIKR.com, has attracted institutional buyers looking to lock in yields. While high interest rates have historically pressured utility stocks by making bonds more competitive, Exelon's regulated rate base growth has helped offset these headwinds.
Historical Recovery Patterns: Why This Cycle Is Different
To understand the significance of the current 130-day recovery, we must compare it to Exelon's historical drawdown behavior. Over its trading history, the stock has experienced 227 total historical drawdown events. However, most of these were minor pullbacks, with an average max drawdown of only -4.0% and an average drawdown duration of 62 days.
When Exelon drops past the 5% threshold, the recovery timeline typically stretches out significantly. The table below outlines how the current drawdown compares to these historical benchmarks.
| Drawdown Metric | Current Drawdown (As of July 31, 2026) | Historical Average (All Events) | Historical 5%+ Drops (44 Occurrences) |
|---|---|---|---|
| Drawdown Depth | -8.9% | -4.0% | -5.0% or deeper |
| Days in Drawdown | 130 days | 62 days | 285 days (average duration) |
| Severity Status | 1.9 (Slightly Elevated) | N/A | N/A |
The stark contrast between the historical 285-day average duration for 5%+ drops and the current 130-day timeline highlights a shift in market structure. In the past, deeper drawdowns occurred when Exelon carried merchant power generation risk, which exposed it to volatile wholesale electricity prices. As a pure-play regulated utility, the company's risk profile is structurally lower today, allowing the stock to stabilize and recover much faster.
What History Says
Article data as of July 31, 2026
EXC has dropped 5%+ from its high 44 times in its tracked history.
Occurrences
44
Avg Duration
285
days
Showing 27 of 44 comparable events from available data. View all
| Period | Max Drop | Duration |
|---|---|---|
| Jul 2008 to Nov 2021 | -62.3% | 4862 days |
| Dec 2000 to Oct 2003 | -40.7% | 1007 days |
| May 1999 to Aug 2000 | -35.9% | 449 days |
| Feb 1996 to May 1998 | -35.3% | 825 days |
| Dec 1989 to Aug 1991 | -34.8% | 611 days |
| Apr 2022 to Mar 2025 | -29.1% | 1076 days |
| Feb 1987 to Feb 1989 | -26.1% | 730 days |
| Sep 1993 to Oct 1995 | -24.7% | 758 days |
Assessing the Current Risk Profile
While the transition to the green zone is a positive technical sign, Exelon is not entirely out of the woods. The stock remains -8.9% below its all-time high of $50.29. The Drawdown Severity Score™ of 1.9 indicates that while the immediate threat of a deeper sell-off has subsided, risk remains slightly elevated compared to a fully recovered state.
According to TradingKey, Exelon's price recently showed minor volatility, closing at $45.28 with a -1.75% daily change shortly before the July 31, 2026 data snapshot. This short-term fluctuation is normal for utility equities adjusting to macroeconomic data. The key difference now is that the broader technical structure has stabilized, preventing the stock from breaking down into the yellow or red severity zones.
Key Technical Thresholds to Monitor
For investors monitoring Exelon's progress, two primary scenarios lie ahead. A continued move toward a full recovery would require the stock to reclaim its previous consolidation levels and push back toward the $50.29 peak. This would likely be driven by continued rate base growth and a more favorable interest rate environment.
Conversely, if macroeconomic pressures mount, we must watch for signs of reversal. A drop back into the yellow zone would occur if the severity score rises above 2.0, which typically correlates with the stock breaking below its recent support levels. Keeping an eye on these zone transitions helps investors distinguish between normal volatility and structural trend changes.
Track EXC's Drawdown Severity Score™
Set a custom alert and get notified when EXC crosses into a new severity zone.
Get Started FreeGet the weekly drawdown digest
A weekly summary of fresh drawdown analysis, market severity changes, and watchlist setup ideas. No per-article blasts.
Frequently Asked Questions
How far has EXC fallen from its all-time high?
As of July 31, 2026, Exelon Corporation (EXC) is down 8.9% from its all-time high of $50.29. The stock is trading at $45.82 after spending 130 days in a drawdown. This decline represents a period of consolidation rather than a deep sell-off for the regulated utility.
What is EXC's drawdown?
As of July 31, 2026, Exelon has a Drawdown Severity Score of 1.9, which is classified as Slightly Elevated. This score indicates that the stock has exited the higher-risk yellow zone and transitioned into the safer green zone. The shift shows that selling pressure has exhausted itself much faster than usual.
How long has EXC been in a drawdown?
As of July 31, 2026, Exelon has been in a drawdown for 130 days. This recovery is notable because it is significantly faster than the historical average recovery duration of 285 days for drops of 5% or more. In 44 comparable prior drops, the stock typically faced much longer periods of consolidation.
Disclaimer: DrawdownAlerts provides historical data analysis, not financial advice. Past performance does not guarantee future results. Severity scores are analytical tools, not buy/sell signals. Always do your own research before making investment decisions.